Thursday, December 29, 2016

BRIEF-Cempra receives complete response letter from FDA for solithromycin NDAs

* Cempra receives complete response letter from FDA for

solithromycin NDAs

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)